iShares Trust - iShares 생명공학 ETF
GB ˙ LSE ˙ US4642875565
US$131.05 ↓ -0.77 (-0.58%)
2023-12-18
주가
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBlair William & Co/il
Latest Disclosed Ownership14,777 shares
Latest Disclosed Value $ 2,495,027
Blair William & Co/il reports 26.56% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 8, 2026 - Blair William & Co/il filed a 13F-HR form disclosing ownership of 14,777 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,495,027 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,676 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 26.56% during the quarter. The current value of the position is $1,936,526 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,777 3,101 26.56 2,495 26.65 0.0071
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,676 -166 -1.40 1,971 15.27 0.0053
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 11,842 -2,440 -17.08 1,710 -5.37 0.0046
2025-07-24 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,282 -8,799 -38.12 1,807 -38.82 0.0050
2025-05-09 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,081 -686 -2.89 2,952 -6.05 0.0089
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 23,767 -40,132 -62.81 3,142 -66.23 0.0091
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 63,899 16,755 35.54 9,304 43.76 0.0273
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 47,144 -3,603 -7.10 6,471 -7.07 0.0200
2024-05-09 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 50,747 5,608 12.42 6,963 13.55 0.0219
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 45,139 -608 -1.33 6,132 9.62 0.0209
2023-11-09 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 45,747 -218 -0.47 5,594 -4.13 0.0215
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 45,965 680 1.50 5,836 -0.24 0.0214
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 45,285 6,075 15.49 5,849 13.64 0.0234
2023-02-10 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 39,210 18,824 92.34 5,148 115.90 0.0224
2022-11-09 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 20,386 2,660 15.01 2,384 14.34 0.0109
2022-08-10 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,726 -991 -5.29 2,085 -14.51 0.0093
2022-05-13 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,717 1,659 9.73 2,439 -6.30 0.0085
2022-02-14 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 17,058 492 2.97 2,603 -2.80 0.0082
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,566 19 0.11 2,678 -1.11 0.0091
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,547 -6,817 -29.18 2,708 -23.02 0.0094
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 23,364 756 3.34 3,518 2.72 0.0133
2021-02-09 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 22,608 -739 -3.17 3,425 8.35 0.0126
2020-11-06 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 23,347 4,486 23.78 3,161 22.61 0.0134
2020-08-12 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 18,861 656 3.60 2,578 31.46 0.0123
2020-05-11 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 18,205 3,334 22.42 1,961 9.43 0.0123
2020-02-13 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 14,871 -564 -3.65 1,792 16.67 0.0092
2019-11-12 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 15,435 -25,431 -62.23 1,536 -65.55 0.0089
2019-08-13 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 40,866 -4,037 -8.99 4,459 -11.18 0.0255
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 44,903 -3,628 -7.48 5,020 7.26 0.0306
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 48,531 -969 -1.96 4,680 -22.47 0.0342
2018-11-13 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 49,500 -6,449 -11.53 6,036 -1.76 0.0370
2018-08-13 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 55,949 8,565 18.08 6,144 21.47 0.0418
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 47,384 -29,523 -38.39 5,058 -38.40 0.0358
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 76,907 64,143 502.53 8,211 92.84 0.0557
2017-11-13 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 12,764 88 0.69 4,258 8.32 0.0319
2017-08-04 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF US 464287556 12,676 850 7.19 3,931 11.90 0.0295
2017-05-10 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 11,826 5 0.04 3,513 11.99 0.0283
2017-02-14 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF US 464287556 11,821 4,624 64.25 3,137 50.60 0.0281
2016-11-14 2016-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF US 464287556 7,197 -3,780 -34.44 2,083 -26.27 0.0184
2016-08-08 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF US 464287556 10,977 4,876 79.92 2,825 77.56 0.0263
2016-05-16 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF US 464287556 6,101 83 1.38 1,591 -21.82 0.0150
2016-02-16 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 6,018 231 3.99 2,035 15.95 0.0191
2015-11-12 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,787 276 5.01 1,755 -13.67 0.0152
2015-08-03 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,511 125 2.32 2,033 9.95 0.0030
2015-05-11 2015-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,386 5,386 0.00 1,849 0.0028
2015-02-05 2014-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 0 -5,747 -100.00 0 -100.00
2014-11-04 2014-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 5,747 -1,928 -25.12 1,572 -20.28 0.0027
2014-08-01 2014-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 7,675 -375 -4.66 1,972 3.63 0.0032
2014-05-06 2014-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 8,050 -3,040 -27.41 1,903 -24.42 0.0031
2014-02-11 2013-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY I ETF 464287556 11,090 -12,705 -53.39 2,518 -49.51 0.0042
2013-11-12 2013-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY I ETF 464287556 23,795 3,565 17.62 4,987 41.80 0.0089
2013-08-07 2013-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY I ETF US 464287556 20,230 20,230 3,517 0.0070
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.